STXS Earnings

STXS reported its earnings on 2026-05-12, showcasing a revenue of against an estimate of 9.10M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.05 by 0%. The stock experienced a -3.65% price change on the earnings day and a -7.29% change over the next five days, reflecting market reactions to the results.

Following STXS's earnings announcement on 2026-05-12, the stock price moved by -3.65% on the day of the release. Over the subsequent five days, it saw a -7.29% change. Historically, STXS's stock price tends to shift by an average of 4.69% in the 10 days leading up to earnings and 4.95% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate STXS's annual revenue to reach 10.17M, while the EPS is projected at -0.05. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between STXS's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, STXS's stock price typically moves by 4.69% in the 10 days before its earnings and 4.95% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.05 and revenue of 10.17M.

The earnings call presents mixed signals: while there are promising developments like ramping up MAGiC catheter production and GenesisX system expansion, financial performance in Q1 2026 was weak with declining revenues and increased losses. The Q&A reveals confidence in future growth, yet lacks concrete timelines and details, which could cause investor hesitation. Given the absence of a market cap and the mixed sentiment, the stock price is likely to remain stable, resulting in a neutral prediction.